Trailing Twelve Months Revenue Growth: zomedica.com (ZOM)

The stability of Zomedica Corp. (ZOM) is underscored by its own laboratories and warehouses in the US, as reflected in the daily chart of rolling year-over-year revenue growth rates on GURU.Markets, where this metric stands at 42.90. The business is driven by pet owner demand for diagnostics, while high profitability is secured by unique patents that allow the company to avoid price wars with medical equipment manufacturers.
Zomedica Corp - analytical breakdowns and key metrics (ZOM)

Trailing twelve-month revenue dynamics, excluding one-time factors, serve as an indicator of the asset's market value through the discounting of future cash flows. By analyzing the annual sales growth rate over a 12-month period, an investor assesses the business resilience of Zomedica Corp. (ZOM), where the implementation of subscription models and the expansion of veterinary tests minimize dependence on volatile retail demand.